-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Insulin degludec in Type 1 diabetes
VS Eligar,S Bain
Review: Clinical Trail Outcomes: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation